InsidersTradesSigma
Track the Enorama Pharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Enorama Pharma AB has published 1 reports. Market capitalisation: €21.2m. The latest transaction was disclosed on 9 September 2025 (Purchase). Among the most active insiders: Bengt Jönsson. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration